Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

BackgroundCausative role of encephalitis in major psychotic features, dyskinesias (particularly orofacial), seizures, and autonomic and respiratory changes has been recently emphasized. These symptoms often occur in young females with ovarian teratomas and are frequently associated with serum and CSF autoantibodies to the NMDA receptor (NMDAR).MethodsThe study included a total of 61 patients from age 15 to 61 and was carried out between January 1, 2005, and Dec 31, 2010. The patients were divided into the following three clinical groups for comparison. Group A; Patients with typical clinical characteristics of anti-NMDAR encephalitis. Group B; Patients with narcolepsy with severe psychosis. Group C; Patients with schizophrenia or schizo-affective disorders.ResultsTen out of 61 cases were anti-NMDAR antibody positive in typical encephalitis cases (group A: 3 of 5 cases) and cases in a broader range of psychiatric disorders including narcolepsy (group B: 3 of 5 cases) and schizophrenia (group C: 4 of 51 cases).ConclusionIn addition to 3 typical cases, we found 7 cases with anti-NMDAR antibody associated with various psychotic and sleep symptoms, which lack any noticeable clinical signs of encephalitis (seizures and autonomic symptoms) throughout the course of the disease episodes; this result suggest that further discussion on the nosology and pathophysiology of autoimmune-mediated atypical psychosis and sleep disorders is required.

• Publication year

  2012

• Venue

  BMC Psychiatry

• Publication date

  2012-05-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1186/1471-244X-12-37PMID 22569157PMCID 3436772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

  2014cited by this paper
• Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.

  2012cited by this paper
• Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

  2011cited by this paper
• A CASE WITH HYPOCRETIN(OREXIN) DEFICIENT NARCOLEPSY, PARKINSON'S DISEASE AND SEVERE PSYCHOSIS WAS SUCCESSFULLY TREATED BY MODIFIED ELECTRO-CONVULSIVE THERAPY

  2011cited by this paper
• Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis.

  2011cited by this paper
• Post-H1N1 narcolepsy-cataplexy.

  2010cited by this paper
• N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

  2010cited by this paper
• A case of NMDAR encephalitis initially suspected psychosis

  2010cited by this paper
• Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis

  2010influential reference
• Disease-relevant autoantibodies in first episode schizophrenia

  2010cited by this paper
• Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications.

  2009cited by this paper
• Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring

  2009cited by this paper
• Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents

  2009cited by this paper
• Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-D-aspartate receptor encephalitis.

  2009cited by this paper
• [Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis].

  2009cited by this paper
• Non-verbal sound processing in the primary progressive aphasias

  2009cited by this paper
• Common variants conferring risk of schizophrenia

  2009cited by this paper
• Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

  2009cited by this paper
• N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

  2009influential reference
• Anti-N-Methyl-D-Aspartate Receptor-Related Grave but Reversible Encephalitis with Ovarian Teratoma in 2 Japanese Women Presenting with Excellent Recovery without Tumor Resection

  2008cited by this paper
• シンポジウム3―2 抗NMDA受容体抗体陽性脳症 抗NMDA受容体脳炎の臨床と病態

  2008cited by this paper
• Anti-NMDA receptor encephalitis in Japan

  2008cited by this paper
• The distinctive movement disorder of ovarian teratoma‐associated encephalitis

  2008cited by this paper
• Paraneoplastic Anti–N-methyl-d-aspartate Receptor Encephalitis Associated with Ovarian Teratoma

  2008cited by this paper
• Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

  2008cited by this paper
• [Clinical features and pathogenesis of anti-NMDA receptor encephalitis].

  2008cited by this paper
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  2007cited by this paper
• The use of electroconvulsive therapy in atypical psychotic presentations: a case review.

  2007cited by this paper
• Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma

  2007cited by this paper
• Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis

  2007cited by this paper
• Sleep

  2007cited by this paper
• A patient with encephalitis associated with NMDA receptor antibodies

  2007cited by this paper
• Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy

  2006cited by this paper
• Acute embolic stroke after electroconvulsive therapy.

  2006cited by this paper
• Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis.

  2006cited by this paper
• Accidental seizure with repetitive transcranial magnetic stimulation.

  2006cited by this paper
• Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level.

  2006cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Erratum: Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence (Molecular Psychiatry (2005) 10 (40-68) DOI:10.1038/sj.mp.4001558))

  2005cited by this paper
• Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis

  2004cited by this paper
• Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

  2004cited by this paper
• Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b.

  1998cited by this paper
• Reversible limbic encephalitis caused by ovarian teratoma

  1997cited by this paper
• An acutely confused 15-year-old girl.

  1997cited by this paper
• Biological mechanisms of schizophrenia and schizophrenia-like psychoses

  1975cited by this paper
• Electroconvulsive therapy in anti-NMDA receptor encephalitis

  year unknowncited by this paper

• Anti-NMDA Receptor Encephalitis: A Narrative Review

  2025cites this paper
• The role of the electroencephalogram (EEG) in determining the aetiology of psychosis: a systematic review and meta-analysis of diagnostic test accuracy.

  2025cites this paper
• Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches.

  2025cites this paper
• First Episode Psychosis in a Teen with Narcolepsy and Cataplexy.

  2025cites this paper
• Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis

  2024cites this paper
• Autoimmune Encephalitis in Catatonic and Treatment-Resistant Psychotic Patients Referred to Electroconvulsive Therapy: Two Case Reports and Systematic Review.

  2024cites this paper
• Bortezomib in the management of anti-NMDA receptor encephalitis

  2023cites this paper
• Case report: Excessive daytime sleepiness as a presenting manifestation of autoimmune glial fibrillary acidic protein astrocytopathy

  2023cites this paper
• Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder/conversion disorder

  2023cites this paper
• Hypothalamic lesion in a neuropsychiatric lupus patient with narcolepsy

  2023cites this paper
• Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review

  2023cites this paper
• Encefalitis anti-receptor NMDA: un diagnóstico a considerar

  2022cites this paper
• Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases

  2022cites this paper
• The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms.

  2022cites this paper
• Seroprevalence of anti-ganglionic acetylcholine receptor antibodies in patients with functional neurological symptom disorder/conversion disorder

  2022cites this paper
• The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data

  2022cites this paper
• Approach to a sleepy child: Diagnosis and treatment of excessive daytime sleepiness in children and adolescents.

  2022cites this paper
• Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review

  2022cites this paper
• Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis

  2021cites this paper
• “Atypical psychoses” and anti‐NMDA receptor encephalitis: A review of literature in the mid‐twentieth century

  2021cites this paper
• A Case Report on Schizophrenia with Autoimmune Encephalitis

  2021cites this paper
• N-methyl-D-aspartate Receptor Antibody and White Matter Deficits in Schizophrenia Treatment-Resistance.

  2021cites this paper
• Rituximab Was Effective for Treatment of Anti–N-Methyl-d-Aspartate Receptor Encephalitis in Early Adolescence in Initially Suspected Dissociative Disorder

  2021cites this paper
• NMDA receptor membrane dynamics tunes the firing pattern of midbrain dopaminergic neurons

  2021cites this paper
• Narcolepsy and psychosis: A systematic review

  2021cites this paper
• Hystero-epilepsy in the Tuesday Lessons and NMDA receptor function: A hypothesis for dissociative disorder.

  2021cites this paper
• Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19

  2021cites this paper
• Antibodies against N-Methyl D-Aspartate Receptor in Psychotic Disorders: A Systematic Review

  2021cites this paper
• Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Detailed Review of the Different Psychiatric Presentations and Red Flags to Look for in Suspected Cases

  2021cites this paper
• Significance of a psychiatry rotation for subjective achievement of competencies related to psychiatry in the Japanese postgraduate residency system

  2021cites this paper
• Endogenous antagonists of N‐methyl‐d‐aspartate receptor in schizophrenia

  2020cites this paper
• Plasmafaresis pada Pasien Status Epileptikus Akibat Ensefalitis Anti-NMDAR di Unit Perawatan Intensif

  2020cites this paper
• Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan

  2020cites this paper
• Anti-N-methyl-D-aspartate Receptor Encephalitis: Case Series of Psychiatric Presentations

  2020cites this paper
• The origin of NMDA receptor hypofunction in schizophrenia.

  2020cites this paper
• Simplex Virus (HSV) NMDA Encephalitis

  2020cites this paper
• Catatonia in N-methyl-d-aspartate receptor antibody encephalitis: Phenomenological characteristics from a systematic review of case reports.

  2020cites this paper
• Psychiatric Symptoms of Patients With Anti-NMDA Receptor Encephalitis

  2020cites this paper
• Neuropsychologische Störungen bei Patienten mit autoimmunen

  2019cites this paper
• Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.

  2019cites this paper
• Catatonia and the immune system: a review

  2019cites this paper
• Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry.

  2019cites this paper
• Autoantibodies and Psychosis.

  2019cites this paper
• Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment

  2019cites this paper
• Anti-NMDA-receptor antibody in initial diagnosis of mood disorder.

  2019cites this paper
• Anti-NMDA receptor antibody positivity in acute psychotic states: An exploratory study.

  2019cites this paper
• Anti-NMDA receptor encephalitis: a case study and illness overview

  2019cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry

  2019cites this paper
• Anti-Hypothalamus and Anti-Pituitary Autoantibodies in ROHHAD Syndrome: Additional Evidence Supporting an Autoimmune Etiopathogenesis

  2019cites this paper
• Clinically Relevant Anti-Neuronal Cell Surface Antibodies in Schizophrenia Spectrum Disorders

  2019cites this paper
• EphBs and ephrin‐Bs: Trans‐synaptic organizers of synapse development and function☆

  2018cites this paper
• Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay

  2018cites this paper
• Hypersomnia

  2018cites this paper
• Autoimmune encephalitis and psychiatric disorders.

  2018cites this paper
• The occurrence of metabolic and inflammatory causes of psychosis in admissions to a psychiatric unit

  2018influential citation
• Autoimmune Encephalitis in Children

  2018cites this paper
• Psychiatric Symptoms and Electroencephalograms in Anti-NMDAR Encephalitis

  2018cites this paper
• “Immune Gate” of Psychopathology—The Role of Gut Derived Immune Activation in Major Psychiatric Disorders

  2018cites this paper
• Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms.

  2018cites this paper
• The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis

  2018cites this paper
• Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

  2017cites this paper
• Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data

  2017cites this paper
• Autoimmune Encephalitis : A Case Report

  2017cites this paper
• The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies

  2017cites this paper
• Brain-relevant antibodies in first-episode psychosis: a matched case–control study

  2017cites this paper
• Autoantikörper als Ursache neuropsychiatrischer Störungsbilder

  2017cites this paper
• Role of glutamate N-Methyl-D-Aspartate receptor surface trafficking in the firing pattern of midbrain dopaminergic neurons

  2017cites this paper
• From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link

  2017cites this paper
• Chronic Schizophrenia Later Diagnosed with Anti-NMDA Receptor Encephalitis: Case Report and Review of the Literature.

  2017cites this paper
• Hallmarks for early recognition of anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: A case report and review of literature

  2017cites this paper
• N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection

  2017cites this paper
• Anticuerpos antineuronales y psicosis

  2017influential citation
• Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia

  2017cites this paper
• Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients

  2017cites this paper
• Autoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice

  2017cites this paper
• Neuroimmune biomarkers in schizophrenia.

  2016cites this paper
• Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii.

  2016cites this paper
• NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?

  2016cites this paper
• Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis

  2016cites this paper
• Anti-Inflammatory Therapy and Immunotherapy Were Partially Effective in a Patient With Anti-N-Methyl-D-Aspartate Receptor Antibodies and a Special Subgroup of Treatment-Resistant Schizophrenia.

  2016cites this paper
• Anti-NMDA (N-metil-D-aszparaginsav) receptor enkefalitisz: irodalmi összefoglaló, esetismertetés és kutatási terv.

  2016cites this paper
• Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient.

  2016influential citation
• Anti‐NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China

  2016cites this paper
• The role of NMDAR antibody in the etiopathogenesis of schizophrenia

  2016cites this paper
• Ultimate Translation: Developing Therapeutics Targeting on N-Methyl-d-Aspartate Receptor.

  2016cites this paper
• Profiling neuronal ion channelopathies with non-invasive brain imaging and dynamic causal models: Case studies of single gene mutations

  2016cites this paper
• Autoantibodies to Neurotransmitter Receptors and Ion Channels in Psychotic Disorders

  2016cites this paper
• Electroconvulsive therapy and/or plasmapheresis in autoimmune encephalitis?

  2016cites this paper
• Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates.

  2016cites this paper
• Toxoplasma gondii and Schizophrenia: A Relationship That Is Not Ruled Out

  2016cites this paper
• Autoantibodies in Neuropsychiatric Disorders

  2016influential citation
• Exploring the presence of narcolepsy in patients with schizophrenia

  2016cites this paper
• Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study

  2016cites this paper
• Autoimmunity in neuropsychiatric disorders.

  2016cites this paper
• Psychotic symptoms in anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A case report and challenges.

  2016cites this paper
• N-Methyl-D-Aspartate Receptor Antibody-Associated Autoimmune Encephalitis

  2016cites this paper
• Anti N-methyl-D-aspartate receptor encephalitis: a game-changer?

  2016influential citation
• Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting With Features of Kleine-Levin Syndrome and Demyelination.

  2016cites this paper
• Beyond Daytime Sleepiness: Medical, Behavioral, Psychiatric, and Sleep Co-morbid Conditions Associated with Pediatric Narcolepsy

  2016cites this paper